4579 — RaQualia Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for RaQualia Pharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,114	2,659	3,926	3,765	3,342
Net Total Accounts Receivable
Net Total Receivables	531	1,205	602	603	689
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,834	4,004	4,822	4,957	4,539
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	333	299	391	574	529
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	4,251	5,234	6,258	6,872	9,655
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	187	401	494	389	1,187
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	240	446	761	752	4,085
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	4,011	4,788	5,497	6,120	5,571
Total Liabilities & Shareholders' Equity	4,251	5,234	6,258	6,872	9,655
Total Common Shares Outstanding